Showing results (201-210 of 291) with videos related to

Sort By:
Pageof 30
Pharmacological Reviews|November 30, 2006
International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptorsLiliane Michalik, Johan Auwerx, Joel P Berger, et al.
Contemporary Clinical Trials|November 9, 2018
European paediatric non-alcoholic fatty liver disease registry (EU-PNAFLD): Design and rationaleJake P Mann, Anita Vreugdenhil, Piotr Socha, et al.
The Journal of Clinical Endocrinology and Metabolism|October 15, 2003
Phenotypic and genetic heterogeneity in congenital generalized lipodystrophyAnil K Agarwal, Vinaya Simha, Elif Arioglu Oral, et al.
The Journal of Clinical Investigation|January 24, 2009
Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosisRobert K Semple, Alison Sleigh, Peter R Murgatroyd, et al.
Endocrinology|June 28, 2014
Functional characterization of obesity-associated variants involving the α and β isoforms of human SH2B1Laura R Pearce, Ray Joe, Michael E Doche, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 30, 2010
CNS leptin action modulates immune response and survival in sepsisJohannes Tschöp, Ruben Nogueiras, Sarah Haas-Lockie, et al.
Nature|November 30, 2018
Trophoblast organoids as a model for maternal-fetal interactions during human placentationMargherita Y Turco, Lucy Gardner, Richard G Kay, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 4, 2014
Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver diseaseFelicity Payne, Koini Lim, Amandine Girousse, et al.
Diabetes|April 7, 2018
A Pharmacogenetic Approach to the Treatment of Patients With PPARG MutationsMaura Agostini, Erik Schoenmakers, Junaid Beig, et al.
Pageof 30